Hi all. I understand that Epitan was meeting with the US FDA this week to seek approval to conduct their phase III trials. I guess this submission must be accompanied with their phase II results (since the trial is already comlplete). Can a III be approved without a succsessful II result? If this is so then it is quite probable that the FDA announcement will not be available until the first week of November (with the II results), if not then won't this be letting the cat out of th bag so to speak with an early announcement of US FDA approval? Stolwyk what do you think?
fda approval
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.98 |
Change
-0.180(1.19%) |
Mkt cap ! $750.1M | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.20 | $14.81 | $979.2K | 65.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1100 | $14.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.98 | 14 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |